(Q37762255)

22 August 2017

1 reference

title

Narcolepsy in Parkinson's disease (English)

1 reference

22 August 2017

0 references

1 reference

4

Kallol Ray Chaudhuri

1 reference

22 August 2017

Imran Z Haq

1

1 reference

22 August 2017

Yogini Naidu

series ordinal

2

1 reference

22 August 2017

Prashanth Reddy

series ordinal

3

1 reference

22 August 2017

publication date

1 June 2010

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

22 August 2017

published in

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

879-884

1 reference

Hypothalamic hypocretin/orexin and neuropeptide Y: divergent interaction with energy depletion and leptin.

22 August 2017

cites work

1 reference

To eat or to sleep? Orexin in the regulation of feeding and wakefulness

21 January 2018

1 reference

Hypocretin/orexin: maintenance of wakefulness and a multiplicity of other roles.

21 January 2018

1 reference

Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans.

21 January 2018

1 reference

Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis

21 January 2018

1 reference

Anti-basal ganglia antibodies in PANDAS.

21 January 2018

1 reference

Direct economic impact of Parkinson's disease: A research survey in the United Kingdom

21 January 2018

1 reference

Non-motor symptoms of Parkinson's disease: diagnosis and management

21 January 2018

1 reference

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

Diagnostic aspects of narcolepsy

21 January 2018

1 reference

21 January 2018

Treatment of narcolepsy

1 reference

Excessive daytime sleepiness in parkinsonism

21 January 2018

1 reference

Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter

21 January 2018

1 reference

Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole

21 January 2018

1 reference

REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease.

21 January 2018

1 reference

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

21 January 2018

1 reference

Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis.

21 January 2018

1 reference

HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease.

21 January 2018

1 reference

Features associated with the development of hallucinations in Parkinson's disease.

21 January 2018

1 reference

Structure and function of human prepro-orexin gene

21 January 2018

1 reference

Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction

21 January 2018

1 reference

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

21 January 2018

1 reference

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

21 January 2018

1 reference

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy

21 January 2018

1 reference

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

21 January 2018

1 reference

Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action

21 January 2018

1 reference

Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

21 January 2018

1 reference

The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats

21 January 2018

1 reference

Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system

21 January 2018

1 reference

Regulation of orexin neurons by the monoaminergic and cholinergic systems.

21 January 2018

1 reference

Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice

21 January 2018

1 reference

The sleep switch: hypothalamic control of sleep and wakefulness

21 January 2018

1 reference

Olfactory disturbances in parkinsonism

21 January 2018

1 reference

Olfactory disturbance in Parkinson disease.

21 January 2018

1 reference

Excessive daytime sleepiness and subsequent development of Parkinson disease

21 January 2018

1 reference

Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study

21 January 2018

1 reference

Hypocretin (orexin) deficiency in human narcolepsy.

21 January 2018

1 reference

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias

21 January 2018

1 reference

Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system

21 January 2018

1 reference

Reduced number of hypocretin neurons in human narcolepsy

21 January 2018

1 reference

Hypocretin/orexin disturbances in neurological disorders

21 January 2018

1 reference

Hypocretin (orexin) loss in Parkinson's disease.

21 January 2018

1 reference

Relationship between CSF hypocretin levels and hypocretin neuronal loss.

21 January 2018

1 reference

Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness.

21 January 2018

1 reference

Parkinson's disease comorbid with narcolepsy presenting low CSF hypocretin/orexin level.

21 January 2018

1 reference

Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.

21 January 2018

1 reference

Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease

21 January 2018

1 reference

Hypocretin (orexin) cell loss in Parkinson's disease.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.10.56

1 reference

22 August 2017

1 reference